Business Description
Kunming Longjin Pharmaceutical Co Ltd
ISIN : CNE1000021X8
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 288.72 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 14.71 | |||||
Beneish M-Score | -2.8 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23.5 | |||||
3-Year EPS without NRI Growth Rate | -16.3 | |||||
3-Year FCF Growth Rate | -131.3 | |||||
3-Year Book Growth Rate | -2.3 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.43 | |||||
9-Day RSI | 34.17 | |||||
14-Day RSI | 36.71 | |||||
6-1 Month Momentum % | -24.5 | |||||
12-1 Month Momentum % | -23.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.84 | |||||
Quick Ratio | 6.32 | |||||
Cash Ratio | 5.77 | |||||
Days Inventory | 416.72 | |||||
Days Sales Outstanding | 75.58 | |||||
Days Payable | 139.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.01 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.66 | |||||
Operating Margin % | -62.13 | |||||
Net Margin % | -87.07 | |||||
FCF Margin % | -70.73 | |||||
ROE % | -13.61 | |||||
ROA % | -10.99 | |||||
ROIC % | -20.61 | |||||
ROC (Joel Greenblatt) % | -46.2 | |||||
ROCE % | -14 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 47.92 | |||||
PS Ratio | 25.48 | |||||
PB Ratio | 4.14 | |||||
Price-to-Tangible-Book | 4.79 | |||||
EV-to-EBIT | -21.81 | |||||
EV-to-EBITDA | -21.81 | |||||
EV-to-Revenue | 21.8 | |||||
EV-to-FCF | -31.63 | |||||
Price-to-Projected-FCF | 8.71 | |||||
Price-to-Net-Current-Asset-Value | 8.1 | |||||
Price-to-Net-Cash | 10.45 | |||||
Earnings Yield (Greenblatt) % | -4.59 | |||||
FCF Yield % | -2.8 | |||||
Forward Rate of Return (Yacktman) % | -30.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kunming Longjin Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 91.239 | ||
EPS (TTM) (Â¥) | -0.198 | ||
Beta | 1.12 | ||
Volatility % | 37.54 | ||
14-Day RSI | 36.71 | ||
14-Day ATR (Â¥) | 0.420158 | ||
20-Day SMA (Â¥) | 6.5825 | ||
12-1 Month Momentum % | -23.57 | ||
52-Week Range (Â¥) | 4.66 - 12.5 | ||
Shares Outstanding (Mil) | 400.5 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kunming Longjin Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kunming Longjin Pharmaceutical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Kunming Longjin Pharmaceutical Co Ltd Frequently Asked Questions
What is Kunming Longjin Pharmaceutical Co Ltd(SZSE:002750)'s stock price today?
When is next earnings date of Kunming Longjin Pharmaceutical Co Ltd(SZSE:002750)?
Does Kunming Longjin Pharmaceutical Co Ltd(SZSE:002750) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |